OncoSec Medical (LTS:0KC7) GF Value Rank: 0 (As of Sep. 22, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

LTS:0KC7 OncoSec Medical Inc LTS:0KC7
40 GF Score
Price $143.00
View Full Analysis

What is OncoSec Medical GF Value Rank?

OncoSec Medical has the GF Value Rank of 0.

GF Value Rank evaluates the exclusive GuruFocus valuation and performance of a stock, rated on a scale from 1 to 10. It is determined by the price-to-GF-Value (P/GF Value) ratio, a proprietary metric calculated based on historical multiples along with an adjustment factor based on a company's past returns and growth and future estimates of the business' performance.

GuruFocus found that for valuation, we cannot simply give stocks a better GF Value rank simply because they have a lower P/GF Value ratio. Backtesting shows that over the long term, the two worst-performing groups are the most expensive group (with the highest P/GF Value ratio) and the least expensive group (with the lowest P/GF Value ratio).

We can understand why the most expensive group underperforms. We were initially puzzled by the underperformance of the least expensive group, but we realized there is a reason why some stocks are super cheap. If they look too undervalued, it is often because the businesses behind them are poor quality. The market realized this and gave them low valuations. In a way, the market is efficient.

After multiple backtesting analyses, we granted the stocks in third-cheapest percentile the highest GF Value rank, as they have performed the best over a full market cycle. Stock performance is actually not as sensitive to valuation as it is to growth and profitability. On average, the companies in the 20%-50% valuation groups have similar performances. Therefore, we should avoid the most expensive and the least expensive stocks. We can be more tolerant of valuation.

A higher score indicates a stock with a relatively low valuation and substantial potential for outperformance. Conversely, a lower score often reflects stocks that are either highly overvalued or deeply undervalued, both of which tend to underperform.

Please click GF Score to see more details on the GF Score's 5 Key Aspects of Analysis.


OncoSec Medical GF Value Rank Related Terms

LTS:0KC7
40GF Score
OncoSec Medical Inc LTS:0KC7
GF Value Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

OncoSec Medical Business Description

Address 820 Bear Tavern Road, Ewing, NJ, USA, 08628-1021
OncoSec Medical Inc. is a clinical-stage biotechnology company based in the United States that develops immunotherapies for cancer. Its lead program, ImmunoPulse IL-12, combines a plasmid encoding the proinflammatory cytokine interleukin-12 with in vivo electroporation to deliver the therapy directly into tumors and stimulate an anti-tumor immune response. The company has studied this approach in indications including metastatic melanoma, triple-negative breast cancer, and other solid tumors, often in combination with checkpoint inhibitors. OncoSec has no approved products and generates no product revenue, funding its research and clinical development through equity financings, partnerships, and collaborations. The company trades over the counter under the ticker ONMA and has faced financial and operational difficulties, including restructuring and going-concern uncertainty.
40GF Score

Get the complete analysis for LTS:0KC7

GF Value Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$143.00
Price